Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia
Saki Matsumoto(University of Lausanne), Aimable Nahimana(University of Lausanne)
Cited by 4
Related Papers
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair
|Cancer Research|2017|108
A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesis
|Autophagy|2014|39
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent
|Oncotarget|2019|22
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
|Pharmaceuticals|2022|20
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia
|Cell Death and Disease|2022|16